FIELD: chemistry.
SUBSTANCE: invention relates to biologically active compounds used in medicine and pharmaceutical industry. Invention object is using L-rhamnopyranosyl-6-O-methyl-D-galacturonan as a hypolipidemic and cholesterol-lowering agent. In particular cases, L-rhamnopyranosyl-6-O-methyl-D-galacturonan can be isolated from birch leaves (Betula pendula L.); can be used as a cholesterol-lowering agent; can be used for hypercholesterolemia therapy in combination with HMG-CoA reductase inhibitors (statins) or in combination with intestinal cholesterol transporter (ezetimibe) blockers.
EFFECT: invention provides enlarging the arsenal of hypolipidemic and cholesterol-lowering agents.
5 cl, 1 dwg, 15 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING HYPOLIPIDEMIC ACTIVITY | 2020 |
|
RU2732503C1 |
METHOD FOR TREATING CHOLELITHIASIS PATIENTS FOR HYPERCHOLESTEROLEMIA STATES BY ADMINISTERING HEPATOSAN PREPARATION ACCELERATING CHOLESTEROL OXIDATION IN LIVER | 2006 |
|
RU2306943C1 |
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
HYPOLIPIDEMIC PHYTOAGENT | 2013 |
|
RU2553309C2 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
ANTIHYPERLIPIDEMIC AGENT (VARIANTS) | 2002 |
|
RU2228746C1 |
AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
Authors
Dates
2019-09-11—Published
2019-06-24—Filed